Boston Scientific Corporation officials announce the U.S. launch of its Charger PTA Balloon Catheter, a 0.035" percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide range of peripheral angioplasty procedures. The Charger PTA Balloon Catheter is Boston Scientific's third new peripheral balloon catheter introduced in 2011 and strengthens the Company's position as a global leader in peripheral angioplasty balloons.
The Charger PTA Balloon Catheter is designed for post-stent dilatation as well as conventional balloon angioplasty to open blocked peripheral arteries. It features high rated burst pressures (up to 20 ATM for selected sizes), rapid deflation, and a low lesion entry profile.
"The Charger PTA Balloon Catheter is designed to deliver results in both routine and challenging cases," says Jeff Mirviss, president of Boston Scientific's Peripheral Interventions Division. "With a low profile and tapered tip, it is engineered to provide excellent push without sacrificing track. The Charger PTA Balloon Catheter complements our growing portfolio of interventional devices for peripheral vasculature procedures."
The Charger PTA Balloon Catheter is compatible with a 6 Fr sheath for 10mm x80mm balloons and is available in a broad range of sizes including 3mm to 12mm diameters and 20mm to 200mm lengths on 75cm or 135cm shafts.
For more information, please visit: http://www.bostonscientific.com/Charger.
Latest from Today's Medical Developments
- Gore completes acquisition of Conformal Medical
- Medical textiles designed for cardiovascular, orthopedic, dental prosthetic applications
- Micro-precision 3D printing: Trends and breakthroughs in medical device manufacturing
- One-component, dual-cure adhesive system for medical device assembly
- #82 Manufacturing Matters - Forecasting 2026 with GIE Media's Manufacturing Group
- Flexing prosthetic finger offers lifelike appearance and movement
- How the fast-evolving defense market impacts suppliers
- Medtronic’s Hugo robotic-assisted surgery system makes US debut